Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean

NCT01982916 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 324

Last updated 2018-03-13

No results posted yet for this study

Summary

The purpose of this study is to evaluate treatment of perennial allergic rhinitis in Korean patients with AGR tablet.

Conditions

  • Allergic Rhinitis
  • Perennial Allergic Rhinitis
  • Non-seasonal Allergic Rhinitis

Interventions

DRUG

AGR tablet

DRUG

Placebo (for AGR tablet and/or Active Comparator)

DRUG

Active Comparator

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    collaborator OTHER
  • Seoul National University Hospital

    collaborator OTHER
  • SMG-SNU Boramae Medical Center

    collaborator OTHER
  • Samsung Medical Center

    collaborator OTHER
  • Kyunghee University Medical Center

    collaborator OTHER
  • Konkuk University Medical Center

    collaborator OTHER
  • Inha University Hospital

    collaborator OTHER
  • Seoul St. Mary's Hospital

    collaborator OTHER
  • Severance Hospital

    collaborator OTHER
  • Ahn-Gook Pharmaceuticals Co.,Ltd

    lead INDUSTRY

Principal Investigators

  • Chae-Seo Rhee, M.D. · Seoul National University Bundang Hospital

  • Tae-Bin Won, M.D. · Seoul National University Hospital

  • Dae-Woo Kim, M.D. · SMG-SNU Boramae Medical Center

  • Hyo-Yeol Kim, M.D. · Samsung Medical Center

  • Sung-Wan Kim, M.D. · Kyunghee University Medical Center

  • Jin-Kook Kim, M.D. · Konkuk University Medical Center

  • Young-Hyo Kim, M.D. · Inha University Hospital

  • Soo-Whan Kim, M.D. · Seoul St. Mary's Hospital

  • Chang-Hoon Kim, M.D. · Severance Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01982916 on ClinicalTrials.gov